SCHEMBL24319745

SCHEMBL24319745

Cc1ccc(-c2cnc3[nH]cc(C(=O)c4c(F)ccc(NS(=O)(=O)N(C)C5CC5)c4F)c3c2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 5/20 0.69
CYP2C19 P33261 11/20 0.60
CYP3A4 P08684 4/20 0.60
RIPK2 O43353 1/20 0.60
ABCB11 O95342 1/20 0.60
EGFR P00533 1/20 0.60
KRAS P01116 1/20 0.60
RAF1 P04049 1/20 0.60
PGR P06401 1/20 0.60
RET P07949 1/20 0.60
CHRM2 P08172 1/20 0.60
ADORA3 P0DMS8 1/20 0.60
ARAF P10398 1/20 0.60
CHRM1 P11229 1/20 0.60
CHRM3 P20309 1/20 0.60
FECH P22830 1/20 0.60
KDR P35968 1/20 0.60
MAP2K2 P36507 1/20 0.60
TGFBR2 P37173 1/20 0.60
NEK2 P51955 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15666473 0.90 BRAF (0.84) BRAFCYP2C19CYP3A4RIPK2ABCB11
SCHEMBL24319518 0.89 BRAF (0.87) BRAFCYP2C19CYP3A4RIPK2ABCB11
SCHEMBL29652446 0.88 BRAF (0.83) BRAFCYP2C19CYP3A4RIPK2ABCB11
SCHEMBL15667737 0.88 BRAF (0.83) BRAFCYP2C19CYP3A4RIPK2ABCB11
SCHEMBL25447399 0.87 BRAF (0.63) BRAFCYP2C19CYP3A4RIPK2ABCB11
SCHEMBL24122918 0.86 BRAF (0.64) BRAFCYP2C19CYP3A4RIPK2ABCB11
SCHEMBL29482984 0.86 BRAF (0.62) BRAFCYP2C19CYP3A4RIPK2ABCB11
SCHEMBL24319429 0.86 BRAF (0.75) BRAFCYP2C19CYP3A4RIPK2ABCB11
SCHEMBL15667173 0.86 CYP2C9 (0.68) BRAFCYP2C19CYP3A4RIPK2ABCB11
SCHEMBL29652310 0.86 CYP2C9 (0.68) BRAFCYP2C19CYP3A4RIPK2ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022047145-A1 RAPIDLY ACCELERATING FIBROSARCOMA PROTEIN DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2022-03-03 WO disclosed